Germany grants BioNTech, CureVac $745 million to speed up coronavirus vaccine workChristian Fernsby ▼ | September 16, 2020
Germany awarded $745 million in funding to BioNTech and CureVac on Tuesday to speed up work on coronavirus vaccines and expand German production capacity.
Topics: Germany BioNTech CureVac
“Even when the world is waiting for a vaccine we won’t take risky short cuts here,” she told a news conference in Berlin.
Karliczek said she does not expect a vaccine to be available for the broader population until the middle of 2021. ■